Torrent Pharmaceuticals Ltd (NSE:TORNTPHARM)
₹ 2612.55 -80.35 (-2.98%) Market Cap: 884.21 Bil Enterprise Value: 912.62 Bil PE Ratio: 59.16 PB Ratio: 13.18 GF Score: 96/100

Q2 2023 Torrent Pharmaceuticals Ltd Earnings Call Transcript

Oct 21, 2022 / 01:00PM GMT
Release Date Price: ₹1573.6 (-1.28%)
Operator

Ladies and gentlemen, good day, and welcome to Q2 FY '23 Earnings Conference Call of Torrent Pharmaceuticals Limited. (Operator Instructions) Please note that this conference is being recorded. I now hand the conference over to Mr. Sudhir Menon. Thank you, and over to you, sir.

Sudhir Menon
Torrent Pharmaceuticals Limited - Executive Director of Finance & CFO

Thank you. Good evening, and welcome to Quarter 3 FY '21 Earnings call. Quarter 2 revenue growth was around 7%, which was rated by performance of the branded generic market, which constituted around 70% of the total revenue and registered a Y-o-Y growth of 13%. Growth in the branded generic market was driven by new launch momentum and performance of the top brands. In terms of financial performance, during the quarter, revenues were INR 2,291 crores, up by 7% on a year-on-year basis. Gross margins were 72% and has improved on a sequential basis. There is a one-off income of INR 7 crores in the line-item operating income. And adjusted for that, the operating EBITDA stands at 29.4%. I now hand over to

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot